Octreotide Acetate recalls

Octreotide Acetate products have been recalled 5 times, most recently on 13 May 2026. The recalling company is usually Teva Pharmaceuticals USA. The most common reason is sterility.

Total recalls5since 2022
Last 12 months4reported
Class I120% of total
Ongoing4latest 13 May 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 20%Class II 4 80%Class III 0 0%

Why octreotide acetate is recalled

Product types

By year

Ongoing octreotide acetate recalls

4 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide

All octreotide acetate recalls, newest first

5 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IIOctreotide Acetate for Injectable Suspension recalledOctreotide AcetateTeva Pharmaceuticals USASterilityNationwide
DrugCLASS IOctreotide Acetate Injection 500 mcg/mL recalled by ViatrisOctreotide AcetateViatrisParticulate MatterNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.